JP2019536764A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536764A5
JP2019536764A5 JP2019523090A JP2019523090A JP2019536764A5 JP 2019536764 A5 JP2019536764 A5 JP 2019536764A5 JP 2019523090 A JP2019523090 A JP 2019523090A JP 2019523090 A JP2019523090 A JP 2019523090A JP 2019536764 A5 JP2019536764 A5 JP 2019536764A5
Authority
JP
Japan
Prior art keywords
benzenesulfonamide
chloro
fluoro
amino
thiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019523090A
Other languages
English (en)
Japanese (ja)
Other versions
JP7072569B2 (ja
JP2019536764A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/058472 external-priority patent/WO2018081384A1/en
Publication of JP2019536764A publication Critical patent/JP2019536764A/ja
Publication of JP2019536764A5 publication Critical patent/JP2019536764A5/ja
Application granted granted Critical
Publication of JP7072569B2 publication Critical patent/JP7072569B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019523090A 2016-10-27 2017-10-26 アシルスルホンアミドNaV1.7阻害剤 Active JP7072569B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662413555P 2016-10-27 2016-10-27
US62/413,555 2016-10-27
PCT/US2017/058472 WO2018081384A1 (en) 2016-10-27 2017-10-26 Acyl sulfonamide nav1.7 inhibitors

Publications (3)

Publication Number Publication Date
JP2019536764A JP2019536764A (ja) 2019-12-19
JP2019536764A5 true JP2019536764A5 (enExample) 2020-11-19
JP7072569B2 JP7072569B2 (ja) 2022-05-20

Family

ID=60245256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019523090A Active JP7072569B2 (ja) 2016-10-27 2017-10-26 アシルスルホンアミドNaV1.7阻害剤

Country Status (8)

Country Link
US (1) US10836758B2 (enExample)
EP (1) EP3532462B1 (enExample)
JP (1) JP7072569B2 (enExample)
KR (1) KR102561076B1 (enExample)
CN (1) CN110088093B (enExample)
ES (1) ES2897998T3 (enExample)
MA (1) MA46615A (enExample)
WO (1) WO2018081384A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018106284A1 (en) 2016-12-09 2018-06-14 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
CA3103600A1 (en) 2018-06-13 2019-12-19 Xenon Pharmaceuticals Inc. Benzenesulfonamide compounds and their use as therapeutic agents
WO2020117626A1 (en) 2018-12-05 2020-06-11 Merck Sharp & Dohme Corp. 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
CN111285825B (zh) * 2018-12-10 2023-02-17 中国科学院上海药物研究所 一类苯磺酰胺取代的衍生物,其制法及其用途
WO2020199683A1 (zh) * 2019-04-04 2020-10-08 上海海雁医药科技有限公司 氮杂环取代的磺酰基苯甲酰胺衍生物、其制法与医药上的用途
WO2020248123A1 (en) 2019-06-11 2020-12-17 Merck Sharp & Dohme Corp. Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity in voltage-gated sodium channels
JP2024534364A (ja) 2021-09-15 2024-09-20 リヒター ゲデオン ニュイルヴァーノシャン ミューコェデー レースヴェーニュタールシャシャーグ (1r,4r)-4-置換シクロヘキサン-1-アミンを生成する方法
TW202530205A (zh) * 2023-10-31 2025-08-01 加拿大商再諾製藥公司 經取代之芳基磺醯胺及其組合物及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2598481B1 (en) * 2010-07-26 2016-08-31 Bristol-Myers Squibb Company Sulfonamide compounds useful as cyp17 inhibitors
MX2014005297A (es) * 2011-10-31 2014-09-11 Xenon Pharmaceuticals Inc Compuestos de bencenosulfonamida y su uso como agentes terapeuticos.
US8889741B2 (en) * 2012-02-09 2014-11-18 Daiichi Sankyo Company, Limited Cycloalkane derivatives
WO2015077905A1 (en) * 2013-11-29 2015-06-04 Merck Sharp & Dohme Corp. Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
CA2944115A1 (en) * 2014-03-29 2015-10-08 Lupin Limited Sulfonamide compounds as voltage gated sodium channel modulators
TW201718629A (zh) * 2015-09-25 2017-06-01 韓美藥品股份有限公司 包含多個生理多肽及免疫球蛋白Fc區之蛋白質接合物
GB201518888D0 (en) * 2015-10-24 2015-12-09 Smiths Medical Int Ltd Medico-surgical tubes and their manufacture
KR20180096683A (ko) * 2015-12-18 2018-08-29 머크 샤프 앤드 돔 코포레이션 전압-게이팅 나트륨 채널에서 선택적 활성을 갖는 디아미노-알킬아미노-연결 아릴술폰아미드 화합물
TW201726637A (zh) * 2015-12-18 2017-08-01 默沙東藥廠 對電位閘控鈉通道具選擇活性之羥基烷基胺-及羥基環烷基胺-取代之二胺-芳基磺胺化合物

Similar Documents

Publication Publication Date Title
JP2019536764A5 (enExample)
US10457638B2 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
RU2458920C2 (ru) Новые соединения
JP6700311B2 (ja) キナーゼ阻害剤である複素環式アミド
JP5203449B2 (ja) 二重nk1/nk3受容体アンタゴニストとしてのピロリジン誘導体
AR038420A1 (es) Compuesto de amida, procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
JP2020502092A5 (enExample)
JP2007519754A5 (enExample)
JP2005526723A5 (enExample)
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
IL205501A (en) Preparation of preparations for the treatment of arthritis
KR20160038008A (ko) 브로모도메인 억제제로서 신규 퀴나졸리논
JP2009513575A5 (enExample)
RU2012138456A (ru) СОЕДИНЕНИЯ 8-МЕТИЛ-1-ФЕНИЛИМИДАЗО[1,5-a]ПИРАЗИНА
SI3075726T1 (en) DERIVATIVES OF UREA OR ITS PHARMACOLOGICAL RECRUITABLE SALTS USED AS FORMIL PEPTIDAL RECEPTOR LIKE 1 (FPRL-1) AGONISTS
JP2005538099A5 (enExample)
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
NO20071314L (no) Peptidiske vasopressinreseptoragonister
JP2019505595A5 (enExample)
JP2017510595A5 (enExample)
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2018501287A (ja) ピリダジノン誘導体および癌の処置におけるそれらの使用
RU2005122615A (ru) Соединения n-(индолэтил)циклоамина
CN101115728A (zh) 三唑取代的氨基二苯甲酮化合物
NO20084674L (no) 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser